ScholarIQanswers from OpenAlex

A randomized controlled trial of licartin for preventing hepatoma recurrence after liver transplantation

PaperCitations, authors & open-access status

A randomized controlled trial of licartin for preventing hepatoma recurrence after liver transplantation is a paper indexed in ScholarIQ from OpenAlex.

How many citations does A randomized controlled trial of licartin for preventing hepatoma recurrence after liver transplantation have?

ScholarIQcitation count

A randomized controlled trial of licartin for preventing hepatoma recurrence after liver transplantation has 184 citations in the OpenAlex counts ScholarIQ stores.

When was A randomized controlled trial of licartin for preventing hepatoma recurrence after liver transplantation published?

ScholarIQyear

A randomized controlled trial of licartin for preventing hepatoma recurrence after liver transplantation has 2007 year in the ScholarIQ index.

What is the open-access status of A randomized controlled trial of licartin for preventing hepatoma recurrence after liver transplantation?

ScholarIQoa status

A randomized controlled trial of licartin for preventing hepatoma recurrence after liver transplantation has hybrid oa status in the ScholarIQ index.

What is the DOI of A randomized controlled trial of licartin for preventing hepatoma recurrence after liver transplantation?

ScholarIQdoi

The DOI for A randomized controlled trial of licartin for preventing hepatoma recurrence after liver transplantation is on the source record.

What is the PMID of A randomized controlled trial of licartin for preventing hepatoma recurrence after liver transplantation?

ScholarIQpmid

The PMID for A randomized controlled trial of licartin for preventing hepatoma recurrence after liver transplantation is on the source record.

What is the OpenAlex record for A randomized controlled trial of licartin for preventing hepatoma recurrence after liver transplantation?

ScholarIQopenalex

The OpenAlex for A randomized controlled trial of licartin for preventing hepatoma recurrence after liver transplantation is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial